March 27th 2025
The prevalence of tobacco use in schizophrenia is over 60%—3 times that of the general population. However, the reason for the high prevalence of tobacco use in schizophrenia remains largely unknown.
Recognizing Toxidromes From Digitally Accessed Illicit Drugs: New Challenges for Psychiatrists
April 18th 2017Access to illicit drugs is now as easy as a few swipes on a smartphone. Here's a primer for clinicians who aren't well acquainted with this trend and who aren’t familiar with the many substances themselves.
Read More
Emerging Treatments and Pharmacogenetics for Cocaine Use Disorder
There are no FDA-approved pharmacotherapies for cocaine use disorder. Here: a review of the off-label use of promising medications for this addiction.
Read More
Managing the Suicidal College Student: Advice for Community Providers
November 23rd 2015Although college students are in many ways similar to any patient in their age group, their environment and stressors differ in significant ways. The authors identify issues to consider in assessing and managing suicidality in this population.
Read More
Opioid Use Disorder: Update on Diagnosis and Treatment
April 30th 2015While opioid dependence is among the most severe and lethal of addictions, it also has the most effective medication treatments. The authors provide 2 case vignettes and a step-by-step process for clinical decision making.
Read More
Marijuana and Madness: Clinical Implications of Increased Availability and Potency
April 30th 2015Current trends are toward relaxing laws on cannabis, but no one knows the likely outcome. Will legalization mean an increase in consumption? Psychiatrists will be on the front lines if and when problems arise.
Read More